Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/1997

01-01-1997

Clinical significance of bcl-2 gene expression in human breast cancer tissues

Authors: Shunzo Kobayashi, Hirotaka Iwase, Yukashi Ito, Hiroko Yamashita, Hiroji Iwata, Toshinari Yamashita, Kazuko Ito, Tatsuya Toyama, Takaaki Nakamura, Akira Masaoka

Published in: Breast Cancer Research and Treatment | Issue 2/1997

Login to get access
Metadata
Title
Clinical significance of bcl-2 gene expression in human breast cancer tissues
Authors
Shunzo Kobayashi
Hirotaka Iwase
Yukashi Ito
Hiroko Yamashita
Hiroji Iwata
Toshinari Yamashita
Kazuko Ito
Tatsuya Toyama
Takaaki Nakamura
Akira Masaoka
Publication date
01-01-1997
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/1997
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1005760013810

Other articles of this Issue 2/1997

Breast Cancer Research and Treatment 2/1997 Go to the issue

OriginalPaper

CeReS-18, a novel cell surface sialoglycopeptide, induces cell cycle arrest and apoptosis in a calcium-sensitive manner

OriginalPaper

Inhibition of hormone and growth factor responsive and resistant human breast cancer cells by CeReS-18, a cell regulatory sialoglycopeptide

OriginalPaper

Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer

OriginalPaper

TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expression

OriginalPaper

Seasonal trends in the self-detection of breast cancer: indications from the Cancer and Steroid Hormone (CASH) study

OriginalPaper

Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits